MNGTracker: Key site for Company All Drugs Sales Analysis

S.No.	Company Name	Short Description	No of Drugs	Company Drug Price	Action
1	AbbVie	AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune diseases; IMBRUVICA, an oral therapy for treating chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, to treat adults with genotype 1 chronic hepatitis C.	4	50.00

S.No.	Updated On	Drug	Price in USD	Action
1	Mar, 2023	Humira Drug Sales & Forecast Humira (adalimumab) is a biologic therapy administered as a subcutaneous injection. It is approved to treat the following autoimmune diseases such as rheu....	15.00	READ	BUY	Your Query
2	Jun, 2020	AdroGel Drug Sales AndroGel (testosterone gel) is a testosterone replacement therapy for males diagnosed with symptomatic low testosterone due to certain underlying conditio....	15.00	READ	BUY	Your Query
3	Jun, 2020	Creon Drug Sales & Forecast Creon (pancrelipase) is a pancreatic enzyme therapy for exocrine pancreatic insufficiency, a condition that occurs in patients with cystic fibrosis, chron....	15.00	READ	BUY	Your Query
4	Jun, 2020	Viekira Pak Drug Sales Viekira Pak is an all-oral, short-course, interferon-free therapy, with or without ribavirin, for the treatment of adult patients with genotype 1 chronic ....	15.00	READ	BUY	Your Query

Useful Links